FDA Approved: BEVESPI AEROSPHERE — Supplemental Application (AstraZeneca Pharmaceuticals LP)

View source ↗

Summary

FDA approved a supplemental application for Bevespi Aerosphere (glycopyrrolate and formoterol fumarate) by AstraZeneca Pharmaceuticals LP.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Bevespi Aerosphere (glycopyrrolate/formoterol fumarate)

Snippet

SUPPL AP for BEVESPI AEROSPHERE (GLYCOPYRROLATE AND FORMOTEROL FUMARATE)